- Social Responsibility
- Social Responsibility
- Our Giving
- Corporate Social Responsibility
- Be The First Tobacco-Free Generation
- Our Impact
- Community Contacts
- Thought Leadership
- Search Jobs
- Investor Story
- Results Center
- 2018 In Review
- Financial Information
- SEC Filings
- Events & Presentations
- Stock Information
- Corporate Governance
- Investor Resources
The Top 5 Stories from the Second Half of 2018
Throughout 2018, our readers were most captivated by issues that shaped the national health care dialogue – from the opioid epidemic to drug pricing transparency to health care transformation. These were the most prominent topics in our round-up of most read articles from January to June, and once again they top the list for the second half of the year.
Here are the top five most read articles from July through December:
Making Progress in the Fight Against Opioid Misuse and Abuse: This article provided updates on our enterprise-wide efforts to address the abuse and misuse of prescription opioids, including supporting safe medication disposal, educating patients at the pharmacy and teens and parents in communities, encouraging appropriate utilization, expanding access to life-saving antidotes and supporting local recovery programs.
Transforming Health Care for Americans: At Town Hall Los Angeles, CVS Health President and CEO Larry Merlo shared his vision for bringing transformative change to health care access and delivery. Here, we recapped Merlo’s explanation of how the combination of CVS Health and Aetna has the potential to make health care easier and less expensive for the consumer.
Our Impact on the Health of America: CVS Health reaches more than 100 million Americans annually in 10,000 communities nationwide. This article highlighted the new CVS Health Impact Dashboard, which showcases how we’re delivering high-quality and affordable care, promoting healthier and safer communities and driving economic impact both locally and nationally.
The Truth Behind Drug Rebates and How to Help Make Drugs More Affordable: CVS Health debunked the myth that rebates are linked to higher drug prices by demonstrating how cost containment strategies from pharmacy benefit managers help offset rising list prices. This article summarized a white paper detailing our innovative tools and solutions that enable CVS Health to provide patients with the right medicine at the lowest possible cost.
Protecting Against the 2018-2019 Flu Season: CVS Health partnered with the Harris Poll to conduct the annual flu survey, which revealed that 22 percent of consumers who didn't get a flu vaccine last year say that knowledge of the 2017-2018 flu season makes them more likely to get vaccinated. This article highlighted why the severity of last year’s flu vaccine serves as a motivating factor to get vaccinated this season.
For more information about CVS Health’s efforts to improve access to quality care across the nation, visit our Quality & Access information center and the CVS Health Impact Dashboard. To stay informed about the latest updates and innovations from CVS Health, register for content alerts and our bi-weekly health care newsletter.